| Literature DB >> 29690517 |
Elisa J Sarmiento1,2, Justin Xavier Moore3,4,5, Leslie A McClure6, Russell Griffin7, Mohammad Z Al-Hamdan8, Henry E Wang9,10.
Abstract
While air pollution has been associated with health complications, its effect on sepsis risk is unknown. We examined the association between fine particulate matter (PM2.5) air pollution and risk of sepsis hospitalization. We analyzed data from the 30,239 community-dwelling adults in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort linked with satellite-derived measures of PM2.5 data. We defined sepsis as a hospital admission for a serious infection with ≥2 systemic inflammatory response (SIRS) criteria. We performed incidence density sampling to match sepsis cases with 4 controls by age (±5 years), sex, and race. For each matched group we calculated mean daily PM2.5 exposures for short-term (30-day) and long-term (one-year) periods preceding the sepsis event. We used conditional logistic regression to evaluate the association between PM2.5 exposure and sepsis, adjusting for education, income, region, temperature, urbanicity, tobacco and alcohol use, and medical conditions. We matched 1386 sepsis cases with 5544 non-sepsis controls. Mean 30-day PM2.5 exposure levels (Cases 12.44 vs. Controls 12.34 µg/m³; p = 0.28) and mean one-year PM2.5 exposure levels (Cases 12.53 vs. Controls 12.50 µg/m³; p = 0.66) were similar between cases and controls. In adjusted models, there were no associations between 30-day PM2.5 exposure levels and sepsis (4th vs. 1st quartiles OR: 1.06, 95% CI: 0.85⁻1.32). Similarly, there were no associations between one-year PM2.5 exposure levels and sepsis risk (4th vs. 1st quartiles OR: 0.96, 95% CI: 0.78⁻1.18). In the REGARDS cohort, PM2.5 air pollution exposure was not associated with risk of sepsis.Entities:
Keywords: air pollution; particulate matter; sepsis
Mesh:
Substances:
Year: 2018 PMID: 29690517 PMCID: PMC5923860 DOI: 10.3390/ijerph15040818
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Breakdown of REGARDS participants used in nested case-control study for the association between short-term PM2.5 exposure and sepsis.
Detailed definitions and technical information for sociodemographics, health behaviors, and chronic medical conditions.
| Characteristics | Definition and/or Technical Information |
|---|---|
|
| |
| Age | Age in years |
| Gender | Male; female |
| Race | African-American; white |
| Education | Participant reported: Less than high school High school graduate Some college College or higher Missing |
| Income | Participant reported: <$20 k $20–$34K $35–$74K ≥$75K Missing (not reported) |
| Geographic Region | Participant residence: Stroke Buckle (coastal plains of North Carolina, South Carolina, and Georgia) Stroke Belt (remainder of North Carolina, South Carolina, and Georgia, plus Tennessee, Mississippi, Alabama, Louisiana, and Arkansas) Non-Belt/Buckle (other states) |
|
| |
| Smoking Status | Participant reported: Current Past Never |
| Alcohol use | Participant reported: None Moderate (up to one drink per day for women or two drinks per day for men) Heavy (>1 drink per day for women and >2 drinks per day for men) [ |
| | |
| Atrial Fibrillation | Participant reported history of atrial fibrillation. |
| Chronic Lung Disease | Participant use of pulmonary medications (beta agonists, leukotriene inhibitors, inhaled corticosteroids, combination inhalers, ipratropium, cromolyn, aminophylline and theophylline) as a surrogate for chronic lung disease. |
| Coronary Artery Disease | Participant reported history of myocardial infarction, coronary artery bypass grafting, or cardiac angioplasty or stenting, or baseline electrocardiographic evidence of myocardial infarction. |
| Diabetes | Fasting glucose ≥126 mg/L (or a glucose ≥200 mg/L for those not fasting) or participant reported use of insulin or oral hypoglycemic agents. |
| Deep Vein Thrombosis | Participant reported history of deep vein thrombosis. |
| Dyslipidemia | Low-density lipoprotein cholesterol >130 mg/dL or participant reported use of lipid lowering medications. |
| Hypertension | Systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or participant reported antihypertensive agent use. |
| Myocardial Infarction | Participant reported history of myocardial infarction or baseline electrocardiographic evidence of myocardial infarction. |
| Obesity | {Waist circumference [>102 cm for males or >88 cm for females]} or {body mass index ≥30 kg/m2}. |
| Peripheral Artery Disease | Participant reported history of lower extremity arterial bypass or leg amputation. |
| Stroke | Participant reported history of stroke or transient ischemic attack. |
Comparison of demographic, substance use, and comorbidity characteristics between sepsis cases and controls. Among 1386 sepsis cases and 5544 controls matched on age (±5 years), race, and sex.
| Sepsis Cases ( | Non-Sepsis Controls * ( | ||
|---|---|---|---|
|
| 68.2 (9.3) | 67.9 (9.1) | - |
|
| |||
| Male | 714 (51.5) | 2856 (51.5) | - |
| Female | 672 (48.5) | 2688 (48.5) | |
|
| |||
| Black | 463 (33.4) | 1852 (33.4) | - |
| White | 923 (66.6) | 3692 (66.6) | |
|
| 231 (16.7) | 580 (10.5) | <0.01 |
|
| 332 (24.0) | 872 (15.7) | <0.01 |
|
| |||
| Stroke Belt a | 527 (38.0) | 1833 (33.1) | <0.01 |
| Buckle b | 294 (21.2) | 136 (20.5) | |
| Non-Stroke Belt c | 565 (40.8) | 2575 (46.5) | |
|
| 59.5 (48.6–65.5) | 59.1 (47.4–72.8) | <0.01 |
|
| 62.4 (56.7–65.7) | 61.9 (54.9–65.6) | 0.03 |
|
| 1.0 | ||
| Fall | 301 (21.7) | 1204 (21.7) | |
| Spring | 371 (26.8) | 1484 (26.8) | |
| Summer | 309 (22.3) | 1236 (22.3) | |
| Winter | 405 (29.2) | 1620 (29.2) | |
|
| |||
| Mixed | 455 (32.9) | 1582 (28.6) | <0.01 |
| Rural | 84 (6.1) | 278 (5.0) | |
| Urban | 844 (61.0) | 3670 (61.0) | |
|
| |||
| Never | 485 (35.2) | 2539 (46.0) | <0.01 |
| Past | 648 (47.0) | 2364 (42.8) | |
| Current | 245 (17.8) | 619 (11.2) | |
|
| |||
| Never | 916 (67.5) | 3341(61.4)) | <0.01 |
| Past | 390 (28.7) | 1846 (34.0) | |
| Current | 52 (3.8) | 251 (4.6) | |
|
| |||
| Atrial fibrillation | 185 (13.6) | 499 (9.2) | <0.01 |
| Chronic lung disease | 263 (19.0) | 453 (8.2) | <0.01 |
| Coronary artery disease | 390 (28.9) | 1089 (20.0) | <0.01 |
| Deep vein thrombosis | 114 (8.3) | 295 (5.3) | <0.01 |
| Diabetes | 447 (32.3) | 1163 (21.0) | <0.01 |
| Dyslipidemia | 865 (65.1) | 3242 (60.4)) | <0.01 |
| Hypertension | 945 (68.5) | 3261 (59.0) | <0.01 |
| Myocardial infarction | 279 (20.6) | 760 (14.0) | <0.01 |
| Obesity | 846 (61.2) | 2718 (49.1) | <0.01 |
| Peripheral artery disease | 64 (4.6) | 94 (1.7) | <0.01 |
| Stroke | 150 (10.9) | 347 (6.3) | <0.01 |
* Matched for age, sex, and race, Mean (Standard deviation), Median (IQR); ** Estimated using conditional logistic regression (Wald test) or paired t-test. a Stroke Buckle (coastal plains of North Carolina, South Carolina, and Georgia). b Stroke Belt (remainder of North Carolina, South Carolina and Georgia, plus Tennessee, Mississippi, Alabama, Louisiana, and Arkansas). c Non-Belt/Buckle (other states).
Figure 2Distribution of average daily mean particulate values for 30-day preceding sepsis case event among 6906 cases and controls.
Odds ratios * (ORs) and associated 95% confidence intervals (CIs) for the association between the preceding 30-day and one-year mean particulate matter 2.5 and incident sepsis. Among 1386 sepsis cases and 5544 controls matched on age (±5 years), race, and sex.
| Unadjusted | Model 1 a | Model 2 b | Model 3 c | |
|---|---|---|---|---|
| Preceding 30-Day Mean OR (95% CI) | ||||
|
| ||||
| Per SD µg/m3 increase | 1.06 (0.98, 1.13) | 1.04 (0.96, 1.12) | 1.03 (0.96, 1.11) | 1.04 (0.96, 1.13) |
| | 0.13 | 0.32 | 0.40 | 0.36 |
|
| ||||
| 1st Quartile (3.27–10.53 µg/m3) | Referent | Referent | Referent | Referent |
| 2nd Quartile (10.53–11.97 µg/m3) | 1.05 (0.88, 1.25) | 0.98 (0.82, 1.17) | 0.98 (0.82, 1.18) | 0.93 (0.76, 1.14) |
| 3rd Quartile (11.97–13.78 µg/m3) | 0.97 (0.82, 1.16) | 0.91 (0.76, 1.09) | 0.90 (0.75, 1.09) | 0.86 (0.70, 1.05) |
| 4th Quartile (13.78–28.11 µg/m3) | 1.14 (0.94, 1.38) | 1.09 (0.89, 1.32) | 1.08 (0.88, 1.32) | 1.06 (0.85, 1.32) |
| | 0.36 | 0.31 | 0.31 | 0.22 |
|
| ||||
|
| ||||
| Per SD µg/m3 increase | 1.03 (0.96, 1.09) | 0.99 (0.92, 1.06) | 0.98 (0.92, 1.05) | 0.98 (0.91, 1.05) |
| | 0.45 | 0.71 | 0.59 | 0.56 |
|
| ||||
| 1st Quartile (5.88–11.48 µg/m3) | Referent | Referent | Referent | Referent |
| 2nd Quartile (11.48–12.58 µg/m3) | 1.10 (0.93, 1.30) | 1.00 (0.84, 1.19) | 0.99 (0.82, 1.18) | 0.99 (0.82, 1.21) |
| 3rd Quartile (12.58–13.53 µg/m3) | 1.15 (0.97, 1.36) | 1.05 (0.88, 1.26) | 1.05 (0.87, 1.26) | 1.04 (0.85, 1.27) |
| 4th Quartile (13.53–20.18 µg/m3) | 1.10 (0.92, 1.32) | 1.00 (0.83, 1.21) | 0.98 (0.81, 1.26) | 0.96 (0.78, 1.18) |
| | 0.44 | 0.92 | 0.88 | 0.87 |
* Estimated using Conditional Logistic Regression. ** Standard Deviation (SD). a Additionally adjusted education, income, region, temperature (30-day or 365 depending on pollution exposure), and urbanicity. b Additionally adjusted for tobacco and alcohol use. c Additionally adjusted for baseline health conditions.
Odds ratios * (ORs) and associated 95% confidence intervals (CIs) for the association between the preceding 30-day and one-year mean particulate matter 2.5 and incident respiratory infection related sepsis. Among 776 total events.
| Unadjusted | Model 1 a | Model 2 b | Model 3 c | |
|---|---|---|---|---|
| Preceding 30-Day Mean OR (95% CI) | ||||
|
| ||||
| Per SD µg/m3 increase | 1.01 (0.91, 1.12) | 0.99 (0.89, 1.11) | 1.00 (0.90, 1.12) | 0.99 (0.87, 1.12) |
| 0.87 | 0.90 | 0.98 | 0.84 | |
|
| ||||
| 1st Quartile (3.27–10.53 µg/m3) | Referent | Referent | Referent | Referent |
| 2nd Quartile (10.53–11.97 µg/m3) | 1.18 (0.93, 1.49) | 1.12 (0.88, 1.43) | 1.16 (0.90, 1.49) | 1.16 (0.87, 1.54) |
| 3rd Quartile (11.97–13.78 µg/m3) | 0.91 (0.71, 1.17) | 0.85 (0.65, 1.10) | 0.87 (0.66, 1.14) | 0.85 (0.63, 1.14) |
| 4th Quartile (13.78–28.11 µg/m3) | 1.06 (0.81, 1.40) | 1.04 (0.78, 1.38) | 1.09 (0.81, 1.47) | 1.04 (0.75, 1.42) |
| 0.17 | 0.16 | 0.13 | 0.18 | |
|
| ||||
|
| ||||
| Per SD µg/m3 increase (SD** = 1.73) | 1.02 (0.94, 1.12) | 0.99 (0.90, 1.09) | 0.99 (0.90, 1.09) | 0.98 (0.88, 1.09) |
| 0.62 | 0.80 | 0.78 | 0.67 | |
|
| ||||
| 1st Quartile (5.88–11.48 µg/m3) | Referent | Referent | Referent | Referent |
| 2nd Quartile (11.48–12.58 µg/m3) | 1.00 (0.79, 1.26) | 0.91 (0.71, 1.17) | 0.87 (0.67, 1.13) | 0.83 (0.62, 1.11) |
| 3rd Quartile (12.58–13.53 µg/m3) | 1.02 (0.80, 1.29) | 0.92 (0.72, 1.19) | 0.95 (0.73, 1.23) | 0.92 (0.68, 1.23) |
| 4th Quartile (13.53–20.18 µg/m3) | 1.03 (0.80, 1.32) | 0.93 (0.72, 1.22) | 0.91 (0.69, 1.20) | 0.85 (0.63, 1.16) |
| 1.00 | 0.89 | 0.77 | 0.60 | |
* Estimated using Conditional Logistic Regression. ** Standard Deviation (SD). a Additionally adjusted education, income, region, temperature (30-day or 365 depending on pollution exposure), and urbanicity. b Additionally adjusted for tobacco and alcohol use. c Additionally adjusted for baseline health conditions.